ESC 365 - What are the predictors of positive response to trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction?

HFA Premium Access

What are the predictors of positive response to trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction?

Session: Poster Session 2 - Chronic Heart Failure – Treatment

Topic: Pharmacotherapy

Speaker: Assistant Professor M. Bohdan (Gdansk, PL)

Event: Heart Failure 2018

Congress Presentation

About the speaker

Assistant Professor Michal Bohdan

Medical University of Gdansk, Gdansk (Poland)

0 follower

61 more presentations in this session

Real-world patterns of loop diuretics dose adjustment and association with outcomes in outpatients with chronic heart failure: observations from the ESC Heart Failure Long-Term Registry

Speaker: Doctor C. Kapelios (Athens, GR)

Acute kidney failure and hyperkalaemia in patients with chronic hearth failure treated with aldosterone antagonists- a risk-benefit network meta-analysis

Intermittent administration of levosimendan ambulatory in patients with advanced chronic heart failure: experience in our center.

Sildenafil for chronic heart failure : a meta-analysis

Speaker: Mrs C. Ariano (Naples, IT)

The dilemma of recurrent hyperkalaemia and use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: a European multi-national targeted chart review

Speaker: Professor P. Rossignol (Monaco, MC)

Access the full session

Poster Session 2 - Chronic Heart Failure – Treatment

Speakers: Assistant Professor M. Bohdan, Doctor C. Kapelios, Mrs C. Ariano, Professor P. Rossignol

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by